Ortal Ben Aharon is an associate in Goodwin’s Antitrust and Competition Law practice. Her practice focuses on helping companies obtain clearance for proposed transactions from the Antitrust Division of the Department of Justice and the Federal Trade Commission. She also counsels clients in assessing the potential antitrust risk of transactions as well as reportability under the Hart-Scott-Rodino Antitrust Improvements Act (HSR).
Ortal’s recent representative experience includes:
- Marlin Equity Partners in its acquisition of Meltwater
- iRobot Corporation in its proposed acquisition by Amazon.com, Inc. for approximately $1.7 billion
- An entity controlled by Sean "Diddy" Combs in its definitive agreement to acquire certain New York, Illinois, and Massachusetts assets from Cresco Labs and Columbia Care to creating the first minority-owned, vertically integrated multi-state cannabis operator for $185 million
- Thoma Bravo in its acquisition of Nearmap for AUD $1.055 billion
- KVH Industries in its sale of Inertial Navigation segment asset to EMCORE for $55 million
- CenExel Clinical Research in its acquisition of Apex Innovative Sciences
- Payspan in its sale to Zelis
- OpenEye in its $500M sale to Cadence Design Systems
- Frazier Healthcare Partners in its sale of Parata Systems to Becton Dickinson & Co. for $1.525 billion
- CSafe Global, a portfolio company of Frazier Healthcare Partners and Thomas H. Lee Partners, in its acquisition of Softbox Systems
- OneLogin in its acquisition by One Identity LLC, a subsidiary of Quest Software Inc.
- Datavant in its merger with CIOX Health for $7 billion
- TaxJar in its acquisition by Stripe
While attending Columbia Law School, Ortal served as an intern for the Federal Trade Commission. Prior to joining Goodwin, Ortal was an associate at Erdinast, Ben Nathan, Toledano & Co. in Tel Aviv.
Columbia Law School
- New York